This inventor holds 1 USPTO granted patent. Top assignee: Carlo Erba. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Innovations of Aurelio Contone
Introduction
Aurelio Contone is a notable inventor based in Como, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address platelet aggregation disorders. His work has implications for the prevention and treatment of various syndromes related to these disorders.
Latest Patents
Aurelio Contone holds a patent for "Isoindoline derivatives having platelet anti-aggregating activity." This patent describes a composition and method for preventing and treating syndromes caused by platelet-aggregation disorders. The active ingredient in this invention is a compound defined by a specific chemical formula, where R can be hydrogen or a C1-C4 alkyl group, and R1 can be hydrogen, a C1-C4 alkyl group, or another specified structure. This innovative approach has the potential to improve therapeutic options for patients suffering from related conditions.
Career Highlights
Aurelio Contone is associated with Carlo Erba, a company known for its contributions to the pharmaceutical industry. His work at Carlo Erba has allowed him to focus on research and development in the field of medicinal chemistry, leading to his successful patent application. His expertise in this area has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Aurelio Contone collaborates with Pier Nicola Giraldi, who is also involved in research and development within the same field. Their partnership exemplifies the importance of teamwork in advancing scientific knowledge and innovation.
Conclusion
Aurelio Contone's contributions to the field of medicinal chemistry, particularly through his patent on isoindoline derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of platelet aggregation disorders.